ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Insiders Cash Out as Buyers Emerge at Albertsons

By ORTEX News · Edited by , Editor, ORTEX News1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

A wave of fresh insider filings this week reveals a clear split: executives at financial and healthcare names are selling, while buyers stepped in at a struggling grocer.

Victoria's Secret exits and safety insurer dumped

Singapore-based investment firm BBRC International filed on July 29 that it sold over $71M worth of VSXY shares on July 28. The block trades — at around $89 per share — signal a major 10% owner reducing exposure after the stock's recent run.

At SAFT, SRB Corp filed a combined $128M in sales filed July 28. The 10% owner offloaded shares at roughly $103 — well above last month's $76 price — locking in gains after a sharp rally.

Medpace founder and execs trim at record highs

MEDP founder and Chairman/CEO August Troendle filed on July 29 that he sold over $4.3M in stock across two trades. An EVP sold another $4.5M block at $600. Multiple insiders selling at the same price level is a clear profit-taking signal.

CFG Chairman and CEO Bruce Van Saun filed July 28 that he sold $9.3M worth of shares on July 24.

Albertsons draws buyers

Bucking the trend, ACI saw CEO Susan Morris and EVP Thomas Moriarty both buy shares this week. Moriarty filed a $1.96M purchase on July 28. Morris added around $450K across two trades filed July 30. The buying came near $11.50 — a sign of confidence at a stock trading near multi-year lows.

This is not financial advice.

Stocks in this article

How this article was generated

Generated
31 Jul 2026, 04:13
Prompt version
v1.0
Data sources
Institutional positioning

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.